project id: TCGA-LUAD; case submitter id: TCGA-55-8620; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 60; days to birth: -22091; days to death: 375; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1952; age at diagnosis: 22091; ajcc pathologic m: M1b; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 66.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 8.438356164383562; pack years smoked: 154.0; years smoked: 47.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; oct embedded: No; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 80.0;